DAFNA Capital Management as of June 30, 2022
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 90 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Sp Biotech Etf Etf (XBI) | 12.4 | $46M | 613k | 74.27 | |
| Stereotaxis Com New (STXS) | 6.9 | $25M | 14M | 1.84 | |
| Biohaven Pharmaceutical Holding | 4.4 | $16M | 110k | 145.71 | |
| Adicet Bio (ACET) | 3.7 | $14M | 936k | 14.60 | |
| Fate Therapeutics (FATE) | 3.7 | $14M | 551k | 24.78 | |
| Xenon Pharmaceuticals (XENE) | 3.6 | $13M | 439k | 30.42 | |
| Blueprint Medicines (BPMC) | 3.6 | $13M | 261k | 50.51 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.5 | $13M | 139k | 92.96 | |
| Ishares Tr Nasdaq Biotech Indx Etf (IBB) | 3.3 | $12M | 103k | 117.63 | |
| Cytokinetics Com New (CYTK) | 2.3 | $8.3M | 212k | 39.29 | |
| Neurocrine Biosciences (NBIX) | 2.2 | $8.1M | 83k | 97.48 | |
| Karuna Therapeutics Ord | 2.1 | $7.9M | 62k | 126.50 | |
| Ideaya Biosciences (IDYA) | 2.1 | $7.6M | 549k | 13.80 | |
| Nurix Therapeutics (NRIX) | 2.0 | $7.2M | 567k | 12.67 | |
| Syndax Pharmaceuticals (SNDX) | 1.9 | $7.1M | 371k | 19.24 | |
| Merus N V (MRUS) | 1.6 | $6.0M | 263k | 22.64 | |
| Revolution Medicines (RVMD) | 1.6 | $5.8M | 300k | 19.49 | |
| Sage Therapeutics (SAGE) | 1.6 | $5.8M | 180k | 32.30 | |
| Alector (ALEC) | 1.5 | $5.6M | 552k | 10.16 | |
| Edgewise Therapeutics (EWTX) | 1.5 | $5.5M | 696k | 7.96 | |
| Dex (DXCM) | 1.5 | $5.4M | 73k | 74.53 | |
| Mirati Therapeutics | 1.5 | $5.3M | 80k | 67.14 | |
| Cymabay Therapeutics | 1.4 | $5.3M | 1.8M | 2.95 | |
| Arcus Biosciences Incorporated (RCUS) | 1.3 | $4.8M | 188k | 25.34 | |
| Natus Medical | 1.3 | $4.7M | 144k | 32.77 | |
| Apellis Pharmaceuticals (APLS) | 1.2 | $4.4M | 97k | 45.22 | |
| Morphic Hldg (MORF) | 1.2 | $4.2M | 196k | 21.70 | |
| Cardiovascular Systems | 1.1 | $4.1M | 287k | 14.36 | |
| Century Therapeutics (IPSC) | 1.1 | $4.0M | 475k | 8.40 | |
| Radius Health Note 3.000% 9/0 (Principal) | 1.1 | $3.9M | 4.0M | 0.98 | |
| Iveric Bio | 1.1 | $3.9M | 403k | 9.62 | |
| Turning Point Therapeutics I | 1.0 | $3.6M | 49k | 75.25 | |
| F-star Therapeutics | 1.0 | $3.6M | 577k | 6.26 | |
| Otonomy | 0.8 | $3.1M | 1.5M | 2.08 | |
| AtriCure (ATRC) | 0.8 | $2.9M | 72k | 40.86 | |
| Kinnate Biopharma | 0.8 | $2.8M | 225k | 12.61 | |
| Axogen (AXGN) | 0.7 | $2.7M | 332k | 8.19 | |
| Kalvista Pharmaceuticals (KALV) | 0.7 | $2.6M | 266k | 9.84 | |
| 89bio (ETNB) | 0.7 | $2.5M | 767k | 3.22 | |
| Dice Therapeutics | 0.7 | $2.4M | 157k | 15.52 | |
| Galapagos Nv Spon Adr (GLPG) | 0.6 | $2.4M | 43k | 55.79 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.6 | $2.2M | 131k | 16.78 | |
| Iteos Therapeutics (ITOS) | 0.6 | $2.2M | 105k | 20.60 | |
| Aerie Pharmaceuticals | 0.6 | $2.2M | 289k | 7.50 | |
| Kura Oncology (KURA) | 0.6 | $2.2M | 118k | 18.33 | |
| Affimed Therapeutics B V | 0.5 | $1.9M | 686k | 2.77 | |
| Mersana Therapeutics (MRSN) | 0.5 | $1.9M | 407k | 4.62 | |
| Oric Pharmaceuticals (ORIC) | 0.5 | $1.9M | 416k | 4.48 | |
| Accuray Incorporated (ARAY) | 0.5 | $1.8M | 942k | 1.96 | |
| Surface Oncology | 0.5 | $1.8M | 1.1M | 1.64 | |
| Biomea Fusion (BMEA) | 0.4 | $1.6M | 137k | 11.98 | |
| Field Trip Health Ord | 0.4 | $1.6M | 1.9M | 0.84 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.4 | $1.4M | 496k | 2.83 | |
| Pardes Biosciences | 0.4 | $1.4M | 451k | 3.07 | |
| Ngm Biopharmaceuticals | 0.4 | $1.4M | 108k | 12.82 | |
| Viking Therapeutics (VKTX) | 0.4 | $1.3M | 462k | 2.89 | |
| Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 0.4 | $1.3M | 1.5M | 0.86 | |
| Mereo Biopharma Group Ads (MREO) | 0.3 | $1.2M | 1.1M | 1.12 | |
| Wave Life Sciences SHS (WVE) | 0.3 | $1.2M | 372k | 3.25 | |
| Regulus Therapeutics (RGLS) | 0.3 | $1.1M | 556k | 2.07 | |
| Keros Therapeutics (KROS) | 0.3 | $1.1M | 39k | 27.64 | |
| Mei Pharma Com New | 0.3 | $1.1M | 1.8M | 0.60 | |
| Neuronetics (STIM) | 0.3 | $1.0M | 314k | 3.21 | |
| Brainsway Sponsored Ads (BWAY) | 0.3 | $966k | 200k | 4.83 | |
| Radius Health Com New | 0.3 | $953k | 92k | 10.37 | |
| Nextcure (NXTC) | 0.2 | $882k | 188k | 4.70 | |
| Scynexis Com New (SCYX) | 0.2 | $845k | 455k | 1.86 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $810k | 75k | 10.82 | |
| Black Diamond Therapeutics (BDTX) | 0.2 | $771k | 314k | 2.46 | |
| Genfit S A Ads (GNFT) | 0.2 | $605k | 188k | 3.22 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.2 | $597k | 351k | 1.70 | |
| Macrogenics (MGNX) | 0.2 | $566k | 192k | 2.95 | |
| Gh Research Ordinary Shares (GHRS) | 0.1 | $549k | 55k | 9.98 | |
| Compass Therapeutics (CMPX) | 0.1 | $525k | 198k | 2.65 | |
| Theseus Pharmaceuticals | 0.1 | $453k | 82k | 5.53 | |
| Venus Concept | 0.1 | $449k | 968k | 0.46 | |
| Rigel Pharmaceuticals Com New | 0.1 | $441k | 390k | 1.13 | |
| Sutro Biopharma (STRO) | 0.1 | $441k | 85k | 5.21 | |
| Masimo Corporation (MASI) | 0.1 | $392k | 3.0k | 130.67 | |
| Compugen Ord (CGEN) | 0.1 | $380k | 205k | 1.85 | |
| Lava Therapeutics Nv SHS (LVTX) | 0.1 | $379k | 128k | 2.95 | |
| Inogen (INGN) | 0.1 | $363k | 15k | 24.20 | |
| Vigil Neuroscience (VIGL) | 0.1 | $257k | 100k | 2.58 | |
| Phasebio Pharmaceuticals | 0.1 | $227k | 379k | 0.60 | |
| Madrigal Pharmaceuticals (MDGL) | 0.1 | $222k | 3.1k | 71.61 | |
| Lineage Cell Therapeutics In (LCTX) | 0.1 | $221k | 140k | 1.58 | |
| Connect Biopharma Hldgs Ads (CNTB) | 0.1 | $218k | 250k | 0.87 | |
| Aslan Pharmaceuticals Ads | 0.0 | $170k | 344k | 0.49 | |
| Annexon (ANNX) | 0.0 | $154k | 41k | 3.77 | |
| Larimar Therapeutics (LRMR) | 0.0 | $98k | 50k | 1.96 |
